PER

1.35%

7.5¢ percheron therapeutics limited

For General Information, page-2848

First 2848 Last

Share
Profile

Follow
arjay

3,556 Posts.

771

14/09/23

09:23

Post #: 69852111
Share

Originally posted by upthedell ↑

Thanks Arjay, I found this to be a powerful paragraph re BIO

With Imugene investor sentiment at all time lows in spite of the company's brilliant science, the chickens must surely be coming home to roost for a management team whose blind faith in their science and perceived disdain for shareholder opinion has left them without a clear and distinct commercial pathway for investors and the market to hang their hat on. At present the lack of upfront or prospective milestone payments for their products, the absence of a corporate partner, such as Roche (see above), has left many wondering what is the road to market for Imugene, and when it is going to occur. Spreading oneself to thin could be the outcome of a strategy wherein Imugene continues to develop multiple oncology platforms across multiple cancer indications. Let us hope this indeed is not the situation, as many more shareholders are now on the register than before the capital raises of recent years began. I guess by building a mini Genentec the long term value of Imugene could indeed be far greater than the sum of their remaining parts, were my above mentioned licensing and partnership scenario to have occurred. However I for one would prefer to see Imugene in a position to develop their best technology, Vaxinia, in order for it to reach its ultimate potential, rather than having to sell the company as a whole prior to that occurring, due to a lack of funds and ongoing revenue. Or to put it bluntly the lack of a commercial partner such as Roche.

Expand

It pretty much sums up the life for a small Biotech which may have potential drug for the market...

Need someone to hold your hand at some stage...and hence JG was pretty clear on partner...

I liked when he said, it's possibly going to be a high value transaction...well no point otherwise isn't it?

Let's see if someone does come on board ...good chance between now and Christmas with trials underway and some companies would prefer to enter now when approvals are in place and drug in few arms
..

Imo

ANP Price at posting: 6.6¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Nine's staff strike as Paris Olympic coverage begins

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

ASX Market Open: ASX200 to rise for Friday session | July 26

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

There are more pages in this discussion • 679 more messages in this thread...

First 2848 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 7.5¢		Change 0.001(1.35%)		Mkt cap ! $67.61M

Open	High	Low	Value	Volume
7.7¢	7.8¢	7.4¢	$24.63K	325.4K

Buyers (Bids)

No.	Vol.	Price($)
2	142779	7.3¢

Sellers (Offers)

Price($)	Vol.	No.
7.5¢	8181	1

View Market Depth

No.	Vol.	Price($)
2	142779	0.073
2	147362	0.072
2	310000	0.071
4	34299	0.070
2	28980	0.069

Price($)	Vol.	No.
0.075	8181	1
0.078	125476	3
0.079	175123	2
0.080	287231	3
0.081	125000	2

Last trade - 16.10pm 26/07/2024 (20 minute delay)

PER (ASX) Chart

For General Information, page-2848

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Nine's staff strike as Paris Olympic coverage begins

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

ASX Market Open: ASX200 to rise for Friday session | July 26

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

For General Information, page-2848

Top Stories

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Nine's staff strike as Paris Olympic coverage begins

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

ASX Market Open: ASX200 to rise for Friday session | July 26

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News